Harvard Bioscience Income from Continuous Operations 2010-2025 | HBIO

Harvard Bioscience income from continuous operations from 2010 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Harvard Bioscience Annual Income from Continuous Operations
(Millions of US $)
2024 $-12
2023 $-3
2022 $-10
2021 $0
2020 $-8
2019 $-5
2018 $-4
2017 $-2
2016 $-4
2015 $-19
2014 $2
2013 $1
2012 $4
2011 $5
2010 $19
2009 $7
Harvard Bioscience Quarterly Income from Continuous Operations
(Millions of US $)
2025-03-31 $-50
2024-12-31 $0
2024-09-30 $-5
2024-06-30 $-3
2024-03-31 $-5
2023-12-31 $-2
2023-09-30 $-1
2023-06-30 $-1
2023-03-31 $1
2022-12-31 $-2
2022-09-30 $-3
2022-06-30 $2
2022-03-31 $-7
2021-12-31 $1
2021-09-30 $0
2021-06-30 $0
2021-03-31 $-1
2020-12-31 $-1
2020-09-30 $-1
2020-06-30 $-2
2020-03-31 $-5
2019-12-31 $1
2019-09-30 $-3
2019-06-30 $0
2019-03-31 $-2
2018-12-31 $3
2018-09-30 $0
2018-06-30 $-1
2018-03-31 $-6
2017-12-31 $0
2017-09-30 $-1
2017-06-30 $-1
2017-03-31 $-1
2016-12-31 $-1
2016-09-30 $-2
2016-06-30 $-1
2016-03-31 $-1
2015-12-31 $-17
2015-09-30 $-1
2015-06-30 $0
2015-03-31 $-1
2014-12-31 $0
2014-09-30 $1
2014-06-30 $1
2014-03-31 $1
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $1
2012-12-31 $3
2012-09-30 $0
2012-06-30 $1
2012-03-31 $1
2011-12-31 $2
2011-09-30 $0
2011-06-30 $1
2011-03-31 $2
2010-12-31 $2
2010-09-30 $13
2010-06-30 $2
2010-03-31 $2
2009-12-31 $4
2009-09-30 $1
2009-06-30 $0
2009-03-31 $2
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.020B $0.094B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $6.636B 18.63
Kewaunee Scientific (KEQU) United States $0.174B 10.99